Development of molecular assays based on epigenetic biomarkers which allow early and reliable cancer diagnostics – this is the intention of oncgnostics!
Our products should allow an early detection of diseases to substantially inprove therapy success. Notice: if detected early, almost all cancer cases are curable.
If you would like us to keep you informed about news related to our company, please sign in for our quarterly newsletter.
oncgnostics GmbH
https://www.oncgnostics.com/wp-content/uploads/2020/10/2020_Post-traumatic-stress_oncgnostics.png
321
846
Ines Sommer
https://www.oncgnostics.com/wp-content/uploads/2015/03/oncgnostics-logo1-300x138.png
Ines Sommer2020-10-09 13:01:202020-10-09 13:01:20On the World Mental Health Day
Africa Studio/Shutterstock.com
https://www.oncgnostics.com/wp-content/uploads/2020/09/shutterstock_398680732_web.jpg
563
845
Ines Sommer
https://www.oncgnostics.com/wp-content/uploads/2015/03/oncgnostics-logo1-300x138.png
Ines Sommer2020-10-02 09:53:492020-10-09 14:13:13Cancer screening: Suddenly, it has an effect on family planning
privat: Dr. Alfred Hansel
https://www.oncgnostics.com/wp-content/uploads/2020/03/202003_Kuba_Alfred_b-scaled.jpg
1920
2560
Ines Sommer
https://www.oncgnostics.com/wp-content/uploads/2015/03/oncgnostics-logo1-300x138.png
Ines Sommer2020-03-24 14:49:072020-10-09 14:13:50Cervical cancer screening in CubaOur fist product, GynTect®, enables reliable and fast diagnosis of cervical cancer and pre-cancerous stages.
Video in German.
